首页> 外文期刊>International journal of molecular medicine >HMOX-1 inhibits TGF-β-induced epithelial-mesenchymal transition in the MCF-7 breast cancer cell line
【24h】

HMOX-1 inhibits TGF-β-induced epithelial-mesenchymal transition in the MCF-7 breast cancer cell line

机译:HMOX-1抑制TGF-β诱导的MCF-7乳腺癌细胞系中的上皮-间质转化

获取原文
       

摘要

Epithelial?mesenchymal transition (EMT) is a key mechanism underlying metastatic breast cancer. Reactive oxygen species (ROS) play an important role in EMT. Heme oxygenase?1 (HMOX?1) can reduce oxidative stress. However, the effect of HMOX?1 on the EMT process in breast cancer cells is unknown. We treated the MCF?7 breast cancer cell line with the HMOX?1 inducer hemin and observed that hemin induced HMOX?1 expression and inhibited migration, invasion and ROS generation in transforming growth factor?β?(TGF?β)?treated MCF?7 cells using quantitative RT?qPCR, western blotting, wound?healing and cell invasion assays as well as fluorescent probe DCFDA. Hemin inhibited TGF?β?induced EMT in the MCF?7 cells, whereas HMOX?1 siRNA attenuated the suppressive effect of hemin as determined by the expression and cellular distribution of selected EMT markers. In summary, our results revealed that hemin treatment increased HMOX?1 expression and inhibited TGF?β?induced EMT in MCF?7 cells.
机译:上皮间质转化(EMT)是转移性乳腺癌的关键机制。活性氧(ROS)在EMT中起重要作用。血红素加氧酶?1(HMOX?1)可以减少氧化应激。但是,HMOXα1对乳腺癌细胞EMT过程的影响尚不清楚。我们用HMOX 1诱导剂血红素处理MCF 7乳腺癌细胞系,并观察到血红素诱导HMOX 1表达,并抑制转化生长因子ββ(TGFββ)处理的MCFβ的迁移,侵袭和ROS生成。使用定量RT?qPCR,蛋白质印迹,伤口愈合和细胞侵袭分析以及荧光探针DCFDA,对7个细胞进行了分析。血红素抑制MCF?7细胞中TGF?β?诱导的EMT,而HMOX?1 siRNA减弱了血红素的抑制作用,这取决于所选EMT标记的表达和细胞分布。总之,我们的结果表明,血红素处理可增加MCF?7细胞中HMOX?1的表达并抑制TGF?β?诱导的EMT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号